glp-1 news today 2025 october 9 ISPOR 2025: Exploring reasons for discontinuation glp-1 news oct 9 2025

The good news is, you can address it without resorting to strong chemical treatments

There is no benefit to reaching target dose faster if cardiovascular side effects become limiting

[20] Patients should contact their GP or bariatric team promptly if they experience any of the following: New or worsening tingling, numbness, or weakness in the limbs Difficulty with balance, coordination, or memory Unexplained fatigue, breathlessness, or palpitations A sore or swollen tongue, or persistent mouth ulcers Any concern that they have missed supplementation for a prolonged period Symptoms that suggest anaemia, such as pallor or dizziness New or worsening neurological symptoms such as paraesthesia, gait disturbance, or cognitive change warrant same-day assessment

ACR: cociente albmina/creatinina

Harvard Health